Provesicles as Novel Drug Delivery Systems

被引:15
作者
Bayindir, Zerrin S. [1 ]
Yuksel, Nilufer [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
Administration routes; characterization; provesicles; proliposomes; proniosomes; vesicular systems; IN-VIVO EVALUATION; ENHANCED INTESTINAL-ABSORPTION; MALTODEXTRIN-BASED PRONIOSOMES; NONIONIC SURFACTANT VESICLES; LOADED NEUTRAL PROLIPOSOMES; IMPROVED ORAL DELIVERY; VITRO SKIN PERMEATION; TRANSDERMAL DELIVERY; CANCER-THERAPY; BIOAVAILABILITY ENHANCEMENT;
D O I
10.2174/1389201016666150206101443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vesicular systems exhibit many attractive properties such as controlled drug release, ability to carry both hydrophilic and hydrophobic drugs, targetability and good biocompatibility. With these unique properties they can provide improved drug bioavailability and reduced side effects. Until now, many vesicular formulations have been studied in clinical and preclinical stages. Nevertheless, the major concern about these systems is their low physicochemical stability and high manufacturing expenses. The stability problems (fusion, aggregation, sedimentation, swelling, and drug leakage during storage) associated with the aqueous nature of vesicular systems hinders their effective usage. The advances on improving the stability of vesicular systems led to the emergence of provesicular systems, which are commonly described as dry, free flowing pre-formulations of vesicular drug delivery systems. Provesicles form vesicular systems upon hydratation with water and exhibit the advantages of vesicular systems with improved stability. The present article briefly reviews vesicular systems (particularly liposomes and niosomes) and enlightens about the innovations in the field. Overall investigations are reviewed and the provesicle approach is explained by giving detailed information on the composition, preparation, administration and characterization methods of provesicular systems (proliposomes and proniosomes). The scope of this article is expected to give insight to the researchers and industrialists to perform further research in this area.
引用
收藏
页码:344 / 364
页数:21
相关论文
共 154 条
  • [1] Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium
    Abd-Elbary, A.
    El-laithy, H. M.
    Tadros, M. I.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 357 (1-2) : 189 - 198
  • [2] Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: Preparation, optimization, in vitro/in vivo evaluation
    Aburahma, Mona Hassan
    Abdelbary, Ghada Ahmed
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 422 (1-2) : 139 - 150
  • [3] Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol
    Agarwal, R
    Katare, OP
    Vyas, SP
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) : 43 - 52
  • [4] Agarwal S. P., 2005, PROGR CONTROLLED NOV, P510
  • [5] Development of a topical niosomal preparation of acetazolamide: preparation and evaluation
    Aggarwal, D
    Garg, A
    Kaur, IP
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (12) : 1509 - 1517
  • [6] Controlled release application of multilamellar vesicles: a novel drug delivery approach
    Agnihotri, Sunil A.
    Soppimath, Kumaresh S.
    Betageri, Guru V.
    [J]. DRUG DELIVERY, 2010, 17 (02) : 92 - 101
  • [7] Provesicular granisetron hydrochloride buccal formulations: In vitro evaluation and preliminary investigation of in vivo performance
    Ahmed, Sami
    El-Setouhy, Doaa Ahmed
    Badawi, Alia Abd El-Latif
    El-Nabarawi, Mohamed Ahmed
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 60 : 10 - 23
  • [8] PROLIPOSOMES AS AN INTRANASAL DOSAGE FORM FOR THE SUSTAINED DELIVERY OF PROPRANOLOL
    AHN, BN
    KIM, SK
    SHIM, CK
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) : 203 - 210
  • [9] Akhilesh D., 2012, International Journal of Pharmaceutical and Chemical Sciences, V1, P164
  • [10] Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir
    Akhter, Sohail
    Kushwaha, Shalini
    Warsi, Musarrat H.
    Anwar, Mohammed
    Ahmad, Mohammad Zaki
    Ahmad, Iqbal
    Talegaonkar, Sushma
    Khan, Zeenat I.
    Khar, Roop K.
    Ahmad, Farhan J.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (01) : 84 - 92